Cytomegalovirus and Herpes Simplex Virus Effect on the Prognosis of Mechanically Ventilated Patients Suspected to Have Ventilator-Associated Pneumonia
|
|
- Milo Chambers
- 6 years ago
- Views:
Transcription
1 Subscription Information for: Cytomegalovirus and Herpes Simplex Virus Effect on the Prognosis of Mechanically Ventilated Patients Suspected to Have Ventilator-Associated Pneumonia Yannael Coisel1*, Sabri Bousbia2, Jean-Marie Forel3, Sami Hraiech3, Bernard Lascola2, Antoine Roch3, Christine Zandotti2, Matthieu Million2, Samir Jaber1, Didier Raoult2, Laurent Papazian3 1 Service d Anesthe sie-re animation Saint Eloi, Centre Hospitalier Universitaire, and INSERM Unite 1046, Universite Montpellier 1, Montpellier, France, 2 UMR CNRS 7278, Universite Aix-Marseille, Marseille, France, 3 Re animation des De tresses Respiratoires et Infections Se ve res, Ho pital Nord, Assistance Publique des Ho pitaux de Marseille, and UMR CNRS 7278, Universite Aix-Marseille, Marseille, France Abstract Objective: Cytomegalovirus (CMV) and herpes simplex virus (HSV) are common viruses that can affect critically ill patients who are not immunocompromised. The aim of this study was to determine whether the identification of CMV and/or HSV in mechanically ventilated critically ill patients suspected of having pneumonia was associated with an increased mortality. Design: Prospective epidemiological study. Setting: Medical intensive care unit of a tertiary medical center. Patients: Ninety-three patients with suspected pneumonia. Interventions: Patients with suspected pneumonia had bronchoalveolar lavage and blood samples taken to confirm the diagnosis. Antigenemia was used to detect CMV in the blood. Bronchoalveolar lavage samples were submitted to testing using quantitative real-time Polymerase Chain Reaction. Measurements and Main Results: We identified 22 patients with a CMV infection, 26 patients with an HSV infection and 45 patients without CMV or HSV infection (control group). Mortality at day 60 was higher in patients with a CMV infection than in patients from the control group (55% vs. 20%, P,0.01). Mortality at day 60 was not significantly increased in the group with HSV infection. Duration of ICU stay and ICU mortality were significantly higher in patients with CMV infections when compared to patients from the control group, whereas ventilator free days were significantly lower in patients with CMV infections when compared to patients from the control group. Conclusions: In critically ill patients, a CMV infection is associated with an increased mortality. Further interventional studies are needed to evaluate whether treatment could improve the prognosis. Citation: Coisel Y, Bousbia S, Forel J-M, Hraiech S, Lascola B, et al. (2012) Cytomegalovirus and Herpes Simplex Virus Effect on the Prognosis of Mechanically Ventilated Patients Suspected to Have Ventilator-Associated Pneumonia. PLoS ONE 7(12): e doi: /journal.pone Editor: Cristina Costa, University Hospital San Giovanni Battista di Torino, Italy Received August 1, 2012; Accepted November 7, 2012; Published December 7, 2012 Copyright: ß 2012 Coisel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: This work was supported by a grant from the Programme Hospitalier de Recherche Clinique The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. * y-coisel@chu-montpellier.fr prognosis [2,7,12]. In a recent retrospective cohort study of intensive care unit (ICU) patients, Miggins et al. [7] reported that an increased risk of death was associated with several viral species, including CMV and HSV. In a previously published study [2], no such impact on outcome was found for HSV infections. Moreover, the recent use of real-time PCR may have modified the epidemiology of such infections [8,25]. We hypothesized that the identification of CMV in blood and/or bronchoalveolar lavage (BAL) samples could be associated with a higher mortality rate when compared to controls that do not develop a viral infection. The aim of the present study was therefore to prospectively evaluate the impact that CMV or HSV has on outcome. A control population of patients not developing these viral infections was Introduction It has been shown for some time that cytomegalovirus (CMV) and herpes simplex virus (HSV) can cause severe disease in immunocompromised patients, either via reactivation of a latent viral infection (the most frequent cause) or via the acquisition of a primary viral infection [1]. More recently, CMV and HSV have been recognized as being pathogenic in critically ill patients who are not receiving immunosuppressive agents [2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]. However, the impact of a CMV or an HSV infection on outcome is still debated [2,10,13,14,17,18,19,20,21,22,23,24]. Only a few studies have concomitantly evaluated the impact of CMV and HSV on PLOS ONE 1 December 2012 Volume 7 Issue 12 e51340
2 Table 1. Characteristics of patients upon admission to the ICU. Overall Population HSV infection group CMV infection group Control group p (n = 93) (n = 26) (n = 22) (n = 45) Age (yr), median [IQR] 63[52 73] 64[54 73] 69[61 75]* 59[43 69] Male gender, n (%) 55 (59) 14 (54) 14 (64) 27 (60) 0.78 SAPS II, median [IQR] 45 [31 55] 50[36 58] 40[31 53] 44[31 55] 0.43 Direct admission from the community, n (%) 65 (69) 19 (73) 10 (45) 36 (80) 0.43 Reason for ICU admission Acute respiratory failure 40 (43) 9 (34) 13 (59) 18 (40) 0.36 Acute exacerbation of chronic respiratory insufficiency 11 (12) 3 (12) 4 (18) 4 (9) Neurologic failure 11 (12) 3 (12) 0 (0) 8 (18) Septic shock 9 (10) 4 (15) 1 (5) 4 (9) Postoperative respiratory failure 8 (8) 1 (4) 2 (9) 5 (11) Cardiogenic shock 4(4) 1(4) 1(5) 2(4) Hemorrhagic shock 2(2) 2(8) 0(0) 0(0) Miscellaneous 8 (9) 3 (12) 1 (5) 4 (9) Immunosuppression on ICU admission, n (%) No immunosupression 84 (90) 23 (88) 21 (95) 40 (89) 0.46 Chemotherapy 2(2) 0(0) 1(5) 1(2) Long-term corticosteroids 6(7) 2(8) 0(0) 4(9) HIV 1(1) 1(4) 0(0) 0(0) Prior ARDS, n (%) 27 (29) 8 (31) 10 (46) 9 (20) 0.10 SAPS II, simplified acute physiologic score II; ARDS, acute respiratory distress syndrome; *p,0.05 vs. No HSV No CMV. doi: /journal.pone t001 used as a comparison. This study was performed in a cohort of mechanically ventilated ICU patients that were suspected of having pneumonia. Materials and Methods A. Ethics Statement The study was approved by the Local Ethics Committee of the Université de la Méditerranée (Marseille, France; approval nu ) which waived the need for written consent, because the protocol did not impact on patient management and complied with standard care in our unit. However, all patients and/or next of kin were informed. B. Study Setting and Population This prospective study was performed in the medical ICU of Sainte-Marguerite University Hospital in Marseille, France. Over a one-year period, all consecutive patients (18 years or older) were prospectively included if they were mechanically ventilated and suspected of having pneumonia. None of the patients were included in a recently published study from the same group [23]. Suspicion of pneumonia was based on the appearance of a new pulmonary infiltrate on chest radiographs, associated with at least 2 of the following criteria: fever.38uc or hypothermia,36uc; white blood cell count /L or, /L; purulent tracheal secretions; or a decrease in the PaO 2 /FiO 2 ratio [26,27]. Fiberoptic bronchoscopy examination was performed in each patient within the first 12 h of suspecting pneumonia. Bronchoalveolar lavage was performed as previously described [27]. BAL samples were tested by RT-PCR, and standard cultures were performed to identify the bacteria and fungi present in the blood and BAL samples [28]. C. Diagnosis of Pneumonia One of the investigators made daily rounds in the ICU to identify eligible patients, to determine the onset of pneumonia based on the diagnostic criteria described below, and to record relevant data from the medical records (bedside flow sheets) and the hospital s mainframe computer, which housed microbiological test results. All chest radiographs were analyzed prospectively by at least two of the investigators. Confirming a diagnosis of bacterial pneumonia required a suspicion of pneumonia and a BAL quantitative culture that grew at least one microorganism at a concentration $10 4 colonyforming units (cfu)/ml. D. Baseline Assessment and Data Collection Each patient s hospital chart was prospectively implemented, and the following data were recorded during admission to the ICU: age, sex, Simplified Acute Physiologic Score II (SAPS II) [29], presence of co-morbidities, and presence of previous immunosuppression or previous Acute Respiratory Distress Syndrome (ARDS). In addition, on the day of sampling, we recorded the Sepsisrelated Organ Failure Assessment (SOFA) score [30], the time spent on a mechanical ventilator from admission to the suspicion of pneumonia, and the CPIS score (Clinical Pulmonary Infection Score) modified by Luna [31]. Other relevant clinical characteristics and outcomes complicating the ICU stay following inclusion (ARDS, bacteremia, bacterial ventilator-associated pneumonia PLOS ONE 2 December 2012 Volume 7 Issue 12 e51340
3 Table 2. Characteristics of patients at the time of diagnosis. All HSV infection group CMV infection group Control group p (n = 93) (n = 26) (n = 22) (n = 45) Duration of mechanical ventilation prior to suspicion of 2 [2 10] 8 [2 12]* 7 [2 14]* 2 [2 5] pneumonia (days), median [IQR] CPIS score, median [IQR] 4 [3 5] 4 [3 5] 3 [2 5] 4 [3 5] 0.57 SOFA score (total), median [IQR] 7 [5 9] 6 [3 9] 7 [5 9] 8 [6 10] 0.43 Prior antibiotics, n (%) 46 (50) 13 (50) 8 (36) 25 (56) 0.34 Enteral nutrition, n (%) 47 (51) 15 (58) 13 (59) 19 (42) 0.30 Closed-suction system, n (%) 29 (31) 7 (27) 8 (36) 14 (31) 0.78 Nasogastric tube, n (%) 66 (71) 20 (77) 16 (73) 30 (67) 0.64 Sedation, n (%) 76 (82) 23 (89) 20 (91) 33 (73) 0.13 NMBA, n (%) 26 (28) 8 (31) 8 (36) 10 (22) 0.45 Anti H2, n (%) 0 (0) 0 (0) 0 (0) 0 (0) 1 Sucralfate, n (%) 1 (1) 0 (0) 0 (0) 1 (2) 0.58 Antacids, n (%) 1 (1) 1 (4) 0 (0) 0 (0) 0.27 Proton-pump inhibitors, n (%) 84 (90) 24 (92) 19 (86) 41 (91) 0.76 Statin, n (%) 9 (10) 2 (8) 4 (18) 3 (7) 0.30 Strict glycemic control, n (%) 10 (10) 4 (15) 2 (9) 4 (9) 0.67 Massive blood transfusion, n (%) 14 (15) 4 (15) 6 (27) 4 (9) 0.14 Intrahospital transfer, n (%) 57 (61) 17 (65) 13 (59) 27 (60) 0.88 Corticosteroids for septic shock, n (%) 37 (40) 12 (46) 12 (55) 13 (29) 0.10 Corticosteroids for ARDS, n (%) 8 (9) 1 (4) 3 (14) 4 (9) 0.48 Activated protein C, n (%) 2 (2) 1 (4) 0 (0) 1 (2) 0.66 Reintubation, n (%) 14 (15) 5 (19) 5 (23) 4 (9) 0.26 CPIS, clinical pulmonary infection score; SOFA, sequential organ failure assessment score; NMBA, Neuromuscular blocking agents; massive blood transfusion, replacement of a patient s total blood volume in less than 24 hours; *p,0.05 vs. No HSV No CMV. doi: /journal.pone t002 (VAP), acute renal failure, shock, ventilator free days and mortality) were also recorded throughout the ICU stay. E. Serologies and Antigenemia Viral serology (IgM and IgG) for cytomegalovirus (CMV) and herpes simplex (HSV) were performed using conventional serological methods with an enzyme linked immunosorbent assay (ELISA). Antigenemia for cytomegalovirus was evaluated using a CINA complete kit (Argene SA, Verniolle, France). Briefly, erythrocytes were lysed by mixing 2 ml of EDTA blood with 8 ml of erythrocyte lysing solution and then centrifuged at 3006g for 10 min. Erythrocyte lysis and centrifugation was repeated twice. Then, the supernatant was discarded and the leukocyte pellet was resuspended in 1 ml of phosphate buffered saline (PBS), counted, and then diluted to cells/ml. One hundred ml (200,000 cells) were cytocentrifuged at 900 rpm for 3 min on glass slides and air-dried. The slides were fixed with a paraformaldehyde solution for 10 min and washed 3 times with PBS. The cells were then incubated for 30 min at 37uC with a mixture of two monoclonal antibodies (1C3 and AYM). After washing with PBS, the slides were incubated for 30 min at 37uC with a secondary antibody conjugated with fluorescein. The slides were then subjected to 3 final washes with PBS, and examined under a fluorescent microscope. The results are given as the number of positive cells per 200,000 cells. Blood PCR was not routinely done when the study was designed. F. Identification of CMV and HSV by PCR on BAL The presence of CMV and HSV was tested with a quantitative real-time PCR. Viral nucleic acids were extracted from 200 ml of BAL fluids with a MDX workstation using a QIAamp Virus BioRobotMDx Kit (Qiagen, Courtaboeuf, France), as recommended by the manufacturer s instructions. Quantitative real time PCR for CMV and HSV was performed using a LightCyclerH instrument (Roche Diagnostics, Meylan, France) with the QuantiTect Probe PCR Kit (Qiagen). HSV was tested with the PolF (59-GGGCCAGGCGCTTGTTGGTGTA-39) and the PolR (59-CATCACCGACCCGGAGAGGGAC-39) primer set (Eurogentec, Seraing, Belgium), and the specific TaqMan probe (6FAM-CCGCCGAACTGAGCAGACACCCGCGC-TAMRA) (Applied Biosystems, Courtaboeuf, France). The presence of CMV was tested with the pp65f (59- GCAGCCACGGGATCGTACT - 39) and the pp65r (59-GGCTTTTACCTCACACGAGCATT- 39) primer set, and the specific TaqMan probe (6FAM-CGCGA- GACCGTGGAACTGCG-TAMRA). The reaction was carried out in 20 ml, in a final volume containing 10 ml of QuantiTect master mix, 0.2 mm of probe, 0.2 mm of each primer, and 4 ml of DNA. The qpcr was initiated by an enzyme-activation incubation at 95uC for 15 min to activate DNA Polymerase, followed by 40 cycles of denaturation at 95uC for 10 s and an annealing-extension step at 60uC for 1 min. Serial dilutions, ranging from 10 2 to 10 5 copies/ml, of synthesized sequences that correspond to the targeted viral genes, were used as positive PLOS ONE 3 December 2012 Volume 7 Issue 12 e51340
4 Figure 1. Viral load on bronchoalveolar lavage for herpes simplex virus (Figure 1A) and cytomegalovirus (Figure 1B) according to mortality at day 60. doi: /journal.pone g001 controls. These dilutions were also used to determine the viral load in positive BAL fluids. A CMV and HSV negative specimen was used as a negative control. G. Definitions The CMV infection group was defined as patients suspected of having pneumonia with positive CMV DNA detection in BAL fluid and/or positive antigenemia and/or the presence of IgM for CMV. We did not differentiate between endogenous reactivation or exogenous infection as the cause of the active infection. The HSV infection group was defined as patients suspected of having pneumonia associated with positive HSV DNA detection in BAL fluid, or the presence of IgM for HSV in patients without CMV identification by antigenemia, real-time PCR or specific IgM. The control group was defined by the absence of a CMV or HSV infection in patients suspected of having pneumonia. A bacterial coinfection required the presence of at least one bacteria at a concentration exceeding 10 4 cfu/ml in the BAL fluid. PLOS ONE 4 December 2012 Volume 7 Issue 12 e51340
5 Table 3. Virological results. All HSV infection group CMV infection group Control group (n = 93) (n = 26) (n = 22) (n = 45) HSV status, n(%) IgM HSV 3(3) 2(8) 1(5) 0(0) IgG HSV 81 (87) 24 (92) 19 (86) 38 (84) BAL RT-PCR 31 (33) 25 (96) 6 (27) 0 (0) CMV status, n(%) IgM CMV 8 (9) 0 (0) 8 (36) 0 (0) IgG CMV 72 (77) 18 (69) 20 (91) 34 (76) BAL RT-PCR 16 (17) 0 (0) 16 (73) 0 (0) Antigenemia 10 (11) 0 (0) 10 (46) 0 (0) BAL, bronchoalveolar lavage; RT-PCR, real time polymerase chain reaction. doi: /journal.pone t003 H. Study Outcomes 1. Primary outcome. The primary outcome was mortality for both viruses, evaluated at day Secondary outcomes. Secondary outcomes were the ICU mortality, the day-28 mortality, the number of days with mechanical ventilation, the number of ventilator-free days (days alive and with a successful weaning from mechanical ventilation for at least 48 hrs) between day 1 and day 28, and between day 1 and day 60 [32]. I. Statistical Analysis Data are expressed as the median with an interquartile range (IQR) or as number of events (percentage). Continuous variables were compared using a Kruskall-Wallis one-way analysis of variance on ranks, with a pairwise multiple comparisons procedure using Dunn s method. The chi-squared test was used to compare categorical variables. All reported P values are two-sided. For all statistical tests used, a p value of,0.05 was considered significant. A Bonferroni method was applied for multiple comparisons when necessary (leading to a significant p value of,0.016 when applied). Multiple logistic regressions were used to adjust the day 60 mortality regarding 2 pre-defined variables (SAPS II score on admission and SOFA score the day of BAL). Results A. Patients Characteristics 1. All patients. During the study period, ninety-three consecutive patients met the inclusion criteria and were prospectively included in the study. Less than one third of all patients were ventilated for ARDS. Ten percent of all patients were previously immunosuppressed (Table 1). 2. Virological status. Twenty-six patients (28%) were included in the HSV group, 22 (24%) in the CMV group, and 45 Table 4. Outcomes. All HSV infection group CMV infection group Control group p (n = 93) (n = 26) (n = 22) (n = 45) Mortality at day 60, n (%) 32 (34) 11 (42) 12 (55)* 9 (20) ICU Mortality, n (%) 32 (34) 11 (42) 12 (55)* 9 (20) Duration of mechanical ventilation (days), median 14 [7 29] 14.5 [10 26] 19.5 [13 44]{ 10 [3 25] [IQR] VFD at day 28 (days), median [IQR] 5 [0 22] 5.5 [0 23] 0 [0 0]{ 18 [0 26] VFD at day 60 (days), median [IQR] 37 [0 54] 36.5 [0 55] 0 [0 25]{ 50 [ ] Duration of ICU stay (days), median [IQR] 16 [9 30] 18 [11 30] 25.5 [15 43]{ 13 [7 28.5] Shock, n (%) 40 (43) 10 (39) 17 (77)*{ 13 (30) Acute renal failure, n (%) 24 (26) 6 (23) 11 (50)* 7 (16) 0.01 Bacteremia, n (%) 19 (20) 3 (12) 10 (46)* 6 (13) ARDS, n (%) 18 (19) 5 (19) 6 (27) 7 (16) 0.52 Bacterial VAP, n (%) 12 (13) 2 (8) 4 (18) 6 (13) 0.55 ICU, intensive care unit; ARDS, acute respiratory distress syndrome; VAP, ventilator-associated pneumonia; BAL, bronchoalveolar lavage; VFD, ventilator-free days. *p,0.01 vs. the No HSV No CMV group; { p,0.05 vs. the No HSV No CMV group; { p,0.016 vs. the HSV group. doi: /journal.pone t004 PLOS ONE 5 December 2012 Volume 7 Issue 12 e51340
6 Figure 2. Meta-analyse of the mortality associated with Cytomegalovirus (CMV) Diagnosis methods are detailed in table 5. doi: /journal.pone g002 patients (48%) were negative for both HSV and CMV (control group). Patients from the CMV group were older (Table 1). As shown in Table 2, there was no significant difference between the three groups at the time of diagnosis, excepting a longer duration of mechanical ventilation in patients from the CMV and the HSV groups before the realization of the BAL as compared with the control group. 3. Virological diagnosis. Eighty-one patients (87%) had IgG for HSV and 72 patients (77%) had IgG for CMV. Thirty-one patients had a positive BAL for HSV using RT-PCR (from to copies/ml, figure 1A) and 16 patients had a positive BAL for CMV using RT-PCR (from to copies/ml, figure 1B). Table 3 shows that antigenemia and RT-PCR were positive for 46% and 73% of the patients exhibiting an active CMV infection, respectively. Eight of the patients with a positive antigenemia for CMV also had a positive RT-PCR for CMV. Finally, all but four patients from the CMV infection group had a positive RT-PCR for CMV performed on BAL samples and/or a positive antigenemia. Only one patient from the HSV group presented IgM with a negative RT-PCR for HSV on BAL. Six patients from the CMV group also had a positive RT-PCR for HSV. By definition, no patient from the HSV group had a positive antigenemia or RT-PCR for CMV. A concomitant confirmed bacterial lung infection was present in 11 patients from the HSV group (42%), 11 (50%) from the CMV group and 16 (36%) from the control group (p = 0.52). Gramnegative bacilli represented respectively 79%, 62% and 72% of the bacteria cultured from BAL. B. Outcomes (Table 4) Mortality at day 60 was higher in patients with a CMV and/or a HSV infection [48% (CI 95 from 35% to 62%)] compared to patients from the control group [20% (CI from 11% to 34%)] (p,0.005). More specifically, mortality at day 60 was higher in patients with a CMV infection [55% (CI 95 from 35% to 73%)] compared with control patients [20% (CI from 11% to 34%)] (p,0.01). This difference remained significant after adjusting for age, SAPS II score on admission and SOFA score on the day of diagnosis. Mortality at day 60 was not significantly higher in the HSV group [42% (CI from 26% to 61%)] compared to the control group. As shown in Figure 1, there was no relationship between mortality at day 60 and the viral load for both the CMV group and the HSV group. Ventilator-free days at D28 and D60 were significantly lower in patients developing an active CMV infection than in patients from the control group. The duration of ICU stay and the ICU mortality rate were significantly higher in patients developing an active CMV infection than in patients from the control group (Table 4). However, there was no difference between the CMV group and the HSV group regarding these parameters. There was no correlation between the viral load and the number of ventilator-free days at D28 and D60 (data not shown). PLOS ONE 6 December 2012 Volume 7 Issue 12 e51340
7 Figure 3. Meta-analyse of the mortality associated with Herpes Simplex Virus (HSV) Diagnosis methods are detailed in table 6. doi: /journal.pone g003 Complications such as bacteremia, acute renal failure or shock were significantly more frequent in the CMV group (Table 4). In contrast, there were no increases in the rate of bacterial VAP or ARDS following virus identification in the CMV group when compared to the other two groups. Discussion The present study suggests that an active CMV infection in critically ill patients increases both crude and adjusted mortalities at day 60. CMV infection was also associated with less ventilator free days at day 28 and day 60, and an increased duration of ICU Table 5. Diagnosis Methods used to diagnose CMV infection. CMV Sample Diagnosis methods Domart 1990 [39] Blood, urine Viral culture Cook 1998 [35] Lower respiratory tract, tracheal aspiration, blood, skin Viral culture Kutza 1998 [37] Blood PP65 antigenemia, PCR Heininger 2001 [4] Blood, lower respiratory tract Viral culture, PCR Cook 2003 [2] Blood, tracheal aspiration Serology, viral culture Jaber 2005 [14] Blood PP65 antigenemia Limaye 2008 [13] Blood PCR Von Muller 2006 [47] Blood, tracheal aspiration, urine Serology, PP65 antigenemia, viral culture in blood, tracheal aspiration and urine Ziemann 2008 [24] Blood PCR Chiche 2009 [23] Blood, lower respiratory tract Serology, PP65 antigenemia, viral culture in BAL Chilet 2010 [34] Blood, tracheal aspiration PCR Heininger 2011 [17] Blood, tracheal aspiration PCR Coisel 2012 Blood, lower respiratory tract Serology, BAL-PCR, PP65 antigenemia BAL, bronchoalveolar lavage; PCR, polymerase chain reaction. doi: /journal.pone t005 PLOS ONE 7 December 2012 Volume 7 Issue 12 e51340
8 Table 6. Diagnosis Methods used to diagnose HSV infection. HSV Sample Diagnosis methods Cook 1998 [35] Lower respiratory tract, tracheal aspiration, blood, skin viral culture Bruynseels 2003 [9] Lower respiratory tract, throat viral culture Cook 2003 [2] Tracheal aspiration viral culture Ong 2004 [38] Lower respiratory tract, throat PCR Engelmann 2007 [36] Lower respiratory tract, tracheal aspiration, throat PCR, viral culture, direct immunofluorescence Luyt 2007 [10] Lower respiratory tract, tracheal aspiration, bronchial biopsies BAL-PCR, BAL-viral culture, cytology Linssen 2008 [18] Lower respiratory tract PCR De Vos 2009 [8] Lower respiratory tract PCR Scheithauer 2010 [19] Lower respiratory tract, tracheal aspiration PCR Smith 2010 [12] Tracheal aspiration PCR Bouza 2011 [48] Lower respiratory tract viral culture Coisel 2012 Blood, lower respiratory Tract Serology, BAL-PCR BAL, bronchoalveolar lavage; PCR, polymerase chain reaction. doi: /journal.pone t006 stay compared with patients without CMV and HSV identification. Infection with a Herpesviridae family virus, namely CMV and HSV, is very common in the general population, whether they are immunosuppressed or not [33,34,35,36,37,38]. In critically ill patients, the incidence of both active CMV and HSV infection is matter of controversy [14,23]. Moreover, many studies were performed in trauma or surgical patients. Serological positivity for CMV reported in critically ill patients ranged from 13% [39] to 100% [40]. Respiratory samples positive for CMV ranged from 0% [41] to 13% [4], antigenemia ranged from 0% [42] to 17% [14], and even 85% in one study [23]. However, the use of open lung biopies found that up to 50% of patients with ARDS were infected with CMV [16]. These differences could be explained by different diagnostic methods for the detection of CMV, including viral culture, antigenemia and PCR assays [22]. Previous studies used culture-based assays (low sensitivity and time-consuming), whereas more recent studies have used antigenemia (more sensitive and quantitative results) or PCR assays [13]. Nevertheless, none of these methods have been validated in ICU patients. Moreover, our results should take in account the relative lack of sensitivity and specificity of some of these diagnostic methods (serology for example). It was likely that some patients with positive virus may actually have infection, whereas other with positive samples may just be false positive. The newest diagnostic methods have not been validated in ICU patients. However, in immunocompromised patients, techniques such as PCR and antigenemia present an adequate diagnostic accuracy [43,44]. CMV reactivation in intensive care patients is not trivial. Indeed, in a study using a murine model, Cook et al. showed that CMV reactivation caused abnormal tumor necrosis factora expression and induced abnormal pulmonary fibrosis, both of which were prevented with ganciclovir [45]. Reactivation of CMV could lead to an increased duration of ventilation or ICU stay in non-immunosuppressed patients in an intensive care setting [2,14,23,24,46,47]. A human study found an independent correlation between CMV reactivation and morbidity in nonimmunosuppressed patients [17], however, there was no correlation with mortality. Another human study found a significant increased mortality rate in patients expressing CMV, but could not demonstrate a cause-effect relationship [20]. In our study, we could identify factors associated with positive CMV samples, but causative links between both had not been addressed. To our knowledge, this is the first study indicating that an active CMV infection in critical care patients increased crude and adjusted mortality at day 60. Our results are concordant with those of Heininger et al. [4], who found that the mortality rate tended to be higher in patients with active CMV infections, with a significant increase in ICU length of stay in survivors. Limaye [13] also found and association between CMV reactivation and a composite end point (prolonged hospitalization or death). In our unit, all patients with an active CMV infection were treated with gancyclovir, which make it difficult to conclude regarding the efficacy of this treatment. Only an interventional trial could conclude if CMV is definitely responsible for a longer duration of mechanical ventilation/los. Indeed, a longer duration of exposure to mechanical ventilation could be associated with an increased risk to identify CMV without any impact on prognosis. This is unlikely because in the present study, patients from the control group were ventilated invasively for a longer period than the time to identify CMV in the CMV group. Figures 2 and 3 represent two meta-analyses of the mortalities associated with CMV and HSV. Even if the diagnostic criteria and the studied populations are very different from one study to another (Tables 5 and 6), these analyses suggest that both CMV and HSV are associated with increased mortality rates. This study strongly suggests that CMV reactivation in critically ill patients is associated with increased mortality. With respect to HSV infections, its impact on various outcome measures seems to be less important when compared to patients infected with CMV. However, only a trial evaluating the efficacy of an anti-viral treatment in ICU patients could demonstrate that CMV and/or HSV alter outcome. Author Contributions Conceived and designed the experiments: YC LP SB BL. Performed the experiments: YC SB JMF SH BL AR CZ MM LP. Analyzed the data: YC LP SB. Wrote the paper: YC LP SJ DR. PLOS ONE 8 December 2012 Volume 7 Issue 12 e51340
9 References 1. Fielding K, Koba A, Grant AD, Charalambous S, Day J, et al. (2011) Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa. PLoS One 6: e Cook CH, Martin LC, Yenchar JK, Lahm MC, McGuinness B, et al. (2003) Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 31: Heininger A, Hamprecht K (2006) How cytomegalorvirus reactivation could cause pulmonary pathology in septic hosts. Crit Care Med 34: Heininger A, Jahn G, Engel C, Notheisen T, Unertl K, et al. (2001) Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 29: Heininger A, Vogel U, Aepinus C, Hamprecht K (2000) Disseminated fatal human cytomegalovirus disease after severe trauma. Crit Care Med 28: Kalil AC, Sun J, Florescu DF (2010) The importance of detecting cytomegalovirus infections in studies evaluating new therapies for severe sepsis. Crit Care Med 38: S Miggins M, Hasan A, Hohmann S, Southwick F, Casella G, et al. The potential influence of common viral infections diagnosed during hospitalization among critically ill patients in the United States. PLoS One 6: e De Vos N, Van Hoovels L, Vankeerberghen A, Van Vaerenbergh K, Boel A, et al. (2009) Monitoring of herpes simplex virus in the lower respiratory tract of critically ill patients using real-time PCR: a prospective study. Clin Microbiol Infect 15: Bruynseels P, Jorens PG, Demey HE, Goossens H, Pattyn SR, et al. (2003) Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. Lancet 362: Luyt CE, Combes A, Deback C, Aubriot-Lorton MH, Nieszkowska A, et al. (2007) Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 175: Porteous C, Bradley JA, Hamilton DN, Ledingham IM, Clements GB, et al. (1984) Herpes simplex virus reactivation in surgical patients. Crit Care Med 12: Smith CA, Conroy LT, Pollock M, Ruddy J, Binning A, et al. (2010) Detection of herpes viruses in respiratory secretions of patients undergoing artificial ventilation. J Med Virol 82: Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, et al. (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. Jama 300: Jaber S, Chanques G, Borry J, Souche B, Verdier R, et al. (2005) Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 127: Papazian L, Fraisse A, Garbe L, Zandotti C, Thomas P, et al. (1996) Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 84: Papazian L, Thomas P, Bregeon F, Garbe L, Zandotti C, et al. (1998) Openlung biopsy in patients with acute respiratory distress syndrome. Anesthesiology 88: Heininger A, Haeberle H, Fischer I, Beck R, Riessen R, et al. (2011) Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 15: R Linssen CF, Jacobs JA, Stelma FF, van Mook WN, Terporten P, et al. (2008) Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. Intensive Care Med 34: Scheithauer S, Manemann AK, Kruger S, Hausler M, Kruttgen A, et al. (2010) Impact of herpes simplex virus detection in respiratory specimens of patients with suspected viral pneumonia. Infection 38: Kalil AC, Florescu DF (2009) Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 37: Kalil AC (2008) A silent killer: cytomegalovirus infection in the nonimmunocompromised critically ill patient. Crit Care Med 36: Chiche L, Forel JM, Papazian L (2011) The role of viruses in nosocomial pneumonia. Curr Opin Infect Dis 24: Chiche L, Forel JM, Roch A, Guervilly C, Pauly V, et al. (2009) Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 37: Ziemann M, Sedemund-Adib B, Reiland P, Schmucker P, Hennig H (2008) Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med 36: Deback C, Luyt CE, Lespinats S, Depienne C, Boutolleau D, et al. (2010) Microsatellite analysis of HSV-1 isolates: from oropharynx reactivation toward lung infection in patients undergoing mechanical ventilation. J Clin Virol 47: Official Statement of the American Thoracic Society, the Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171: Jung B, Embriaco N, Roux F, Forel JM, Demory D, et al. (2010) Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score. Intensive Care Med 36: Bousbia S, Papazian L, La Scola B, Raoult D (2010) Detection of plant DNA in the bronchoalveolar lavage of patients with ventilator-associated pneumonia. PLoS One 5: e Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. Jama 270: Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, et al. (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on sepsis-related problems of the European Society of Intensive Care Medicine. Crit Care Med 26: Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, et al. (2003) Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 31: Schoenfeld DA, Bernard GR (2002) Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 30: Sanadgol N, Ramroodi N, Ahmadi GA, Komijani M, Moghtaderi A, et al. (2011) Prevalence of cytomegalovirus infection and its role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis. New Microbiol 34: Chilet M, Aguilar G, Benet I, Belda J, Tormo N, et al. (2010) Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. J Med Virol 82: Cook CH, Yenchar JK, Kraner TO, Davies EA, Ferguson RM (1998) Occult herpes family viruses may increase mortality in critically ill surgical patients. Am J Surg 176: Engelmann I, Gottlieb J, Meier A, Sohr D, Ruhparwar A, et al. (2007) Clinical relevance of and risk factors for HSV-related tracheobronchitis or pneumonia: results of an outbreak investigation. Crit Care 11: R Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G (1998) High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 26: Ong GM, Lowry K, Mahajan S, Wyatt DE, Simpson C, et al. (2004) Herpes simplex type 1 shedding is associated with reduced hospital survival in patients receiving assisted ventilation in a tertiary referral intensive care unit. J Med Virol 72: Domart Y, Trouillet JL, Fagon JY, Chastre J, Brun-Vezinet F, et al. (1990) Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery. Chest 97: Stephan F, Meharzi D, Ricci S, Fajac A, Clergue F, et al. (1996) Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilation. Intensive Care Med 22: Daubin C, Vincent S, Vabret A, du Cheyron D, Parienti JJ, et al. (2005) Nosocomial viral ventilator-associated pneumonia in the intensive care unit: a prospective cohort study. Intensive Care Med 31: Desachy A, Ranger-Rogez S, Francois B, Venot C, Traccard I, et al. (2001) Reactivation of human herpesvirus type 6 in multiple organ failure syndrome. Clin Infect Dis 32: Drew WL (2007) Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. Curr Opin Infect Dis 20: Piiparinen H, Helantera I, Lappalainen M, Suni J, Koskinen P, et al. (2005) Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients. J Med Virol 76: Cook CH, Zhang Y, Sedmak DD, Martin LC, Jewell S, et al. (2006) Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice. Crit Care Med 34: Limaye AP, Boeckh M (2010) CMV in critically ill patients: pathogen or bystander? Rev Med Virol 20: von Muller L, Klemm A, Weiss M, Schneider M, Suger-Wiedeck H, et al. (2006) Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis 12: Bouza E, Giannella M, Torres MV, Catalan P, Sanchez-Carrillo C, et al. (2011) Herpes simplex virus: a marker of severity in bacterial ventilator-associated pneumonia. J Crit Care 26: 432 e PLOS ONE 9 December 2012 Volume 7 Issue 12 e51340
Herpes virus reactivation in the ICU. M. Ieven BVIKM
Herpes virus reactivation in the ICU M. Ieven BVIKM 07.04.2011 Introduction: Viruses identified in critically ill ICU patients Viral diseases have recently been the subject of numerous investigations in
More informationThe role of viruses in nosocomial pneumonia Laurent Chiche, Jean-Marie Forel and Laurent Papazian
The role of viruses in nosocomial pneumonia Laurent Chiche, Jean-Marie Forel and Laurent Papazian Réanimation Médicale, Assistance Publique Hôpitaux de Marseille, URMITE CNRS-UMR 6236, Université de la
More informationCytomegalovirus in critically ill patients
! Cytomegalovirus in critically ill patients Frédéric Pène Medical ICU, Hôpital Cochin, AP-HP, Paris, France Université Paris Descartes, Sorbonne Paris Cité Institut Cochin, Inserm U1016, CNRS UMR-8104
More informationJOURNAL OF BIOMEDICINE AND TRANSLATIONAL RESEARCH
Journal of Biomedicine and Translational Research 01(2015) 2-10 JOURNAL OF BIOMEDICINE AND TRANSLATIONAL RESEARCH J.Biomed.Transl. Res ISSN: 2503-2178 Copyright 2017 by Faculty of Medicine Diponegoro University
More informationViral-reactivated pneumonia during mechanical ventilation: is there need for antiviral treatment?
REVIEW ARTICLE published: 08 November 2011 doi: 10.3389/fphar.2011.00066 Viral-reactivated pneumonia during mechanical ventilation: is there need for antiviral treatment? Alejandra López-Giraldo 1,2,3,
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More informationChapter 5 Clinical correlates of herpes simplex virus type 1 loads in the lower respiratory tract of critically ill patients
Chapter 5 Clinical correlates of herpes simplex virus type 1 loads in the lower respiratory tract of critically ill patients Evelien Assink- de Jong, AB Johan Groeneveld, Annika Pettersson, Alex Koek,
More informationANWICU knowledge
ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted
More informationSupplementary Online Content
Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory
More informationDiagnosing Pneumonia during Mechanical Ventilation The Clinical Pulmonary Infection Score Revisited
Diagnosing Pneumonia during Mechanical Ventilation The Clinical Pulmonary Infection Score Revisited Muriel Fartoukh, Bernard Maître, Stéphanie Honoré, Charles Cerf, Jean-Ralph Zahar, and Christian Brun-Buisson
More informationDiagnosis of Ventilator- Associated Pneumonia: Where are we now?
Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Gary French Guy s & St. Thomas Hospital & King s College, London BSAC Guideline 2008 Masterton R, Galloway A, French G, Street M, Armstrong
More informationCytomegalovirus infection in immunocompetent critically ill adults: literature review
DOI 10.1186/s13613-016-0207-8 REVIEW Open Access Cytomegalovirus infection in immunocompetent critically ill adults: literature review Awad Al Omari 1,2*, Fadi Aljamaan 3, Waleed Alhazzani 4, Samer Salih
More informationOLB (Open Lung Biopsy) in ARDS
OLB (Open Lung Biopsy) in ARDS Claude GUERIN MD PhD Réanimation Médicale Hôpital de la Croix-Rousse Université de Lyon Lyon, France CCF Toronto October 28 th 2012 CCF 2012 1 Disclosure No conflict of interest
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY
HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health
More informationVAP Are strict diagnostic criteria advisable?
VAP Are strict diagnostic criteria advisable? Javier Garau, MD, PhD 18th Infection and Sepsis Symposium, Porto, 27th February 2013 Limitations of current definitions Alternatives -Streamlined definition
More informationMICROBIOLOGICAL TESTING IN PICU
MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes
More informationClinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract
New Microbiologica, 40, 2, 107-112, 2017, ISN 1121-7138 Clinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract Francesca Pica 1, Marco Ciotti 5 *, Massimo
More informationTranspla. antation. Associate Professor of Medical Virology Virology Research Center Shahid Beheshti University of Medical Sciences
Viral Mo olecular Diagno osis in Transpla antation Seyed Alireza Nadji, Ph.D. Associate Professor of Medical Virology Virology Research Center Shahid Beheshti University of Medical Sciences Which techniques
More informationNew Surveillance Definitions for VAP
New Surveillance Definitions for VAP 2012 Critical Care Canada Forum Toronto Dr. John Muscedere Associate Professor of Medicine, Queen s University Kingston, Ontario Presenter Disclosure Dr. J. G. Muscedere
More informationClinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract
Full paper Clinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract Francesca Pica 1, Marco Ciotti 5 *, Massimo Maurici 2 *, Cristina Buè 1, Paolo Nardi 1, Gabriella
More informationUsefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège
Usefulness of Procalcitonin in the management of Infections in ICU P Damas CHU Sart Tilman Liège Procalcitonin Peptide 116 AA Produced by parenchymal cells during «sepsis»: IL1, TNF, IL6 : stimulators
More informationARDS during Neutropenia. D Mokart DAR IPC GRRRRROH 2010
ARDS during Neutropenia D Mokart DAR IPC GRRRRROH 2010 Definitions Neutropenia is a decrease in circulating neutrophil white cells in the peripheral blood. neutrophil count of 1,000 1,500 cells/ml = mild
More informationDisclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice
Procalcitonin: Pearls and Pitfalls in Daily Practice Sarah K Harrison, PharmD, BCCCP Clinical Pearl Disclosures The author of this presentation has no disclosures concerning possible financial or personal
More informationL utilizzo della Procalcitonina in Medicina d Urgenza
L utilizzo della Procalcitonina in Medicina d Urgenza Stefania Battista Dirigente Medico S.C. Medicina d Urgenza Azienda Ospedaliero-Universitaria San Giovanni Battista di Torino Savona, 15 ottobre 2009
More informationFAILURE OF NONINVASIVE VENTILATION FOR DE NOVO ACUTE HYPOXEMIC RESPIRATORY FAILURE: ROLE OF TIDAL VOLUME
FAILURE OF NONINVASIVE VENTILATION FOR DE NOVO ACUTE HYPOXEMIC RESPIRATORY FAILURE: ROLE OF TIDAL VOLUME Guillaume CARTEAUX, Teresa MILLÁN-GUILARTE, Nicolas DE PROST, Keyvan RAZAZI, Shariq ABID, Arnaud
More informationImpact of humidification and gas warming systems on ventilatorassociated
Online Data Supplement Impact of humidification and gas warming systems on ventilatorassociated pneumonia. Jean-Claude Lacherade, M.D. 1, Marc Auburtin, M.D. 2, Charles Cerf, M.D. 3, Andry Van de Louw,
More informationPolmoniti: Steroidi sì, no, quando. Alfredo Chetta Clinica Pneumologica Università degli Studi di Parma
Polmoniti: Steroidi sì, no, quando Alfredo Chetta Clinica Pneumologica Università degli Studi di Parma Number of patients Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION
HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health Care Medical
More informationInvasive Pulmonary Aspergillosis in
Infection & Sepsis Symposium Porto, April 1-3, 2009 Invasive Pulmonary Aspergillosis in Non-Immunocompromised Patients Stijn BLOT, PhD General Internal Medicine & Infectious Diseases Ghent University Hospital,
More informationOnline data supplement
Online data supplement Predicting Survival after Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Failure: the Respiratory ECMO Survival Prediction (RESP)-Score. Matthieu Schmidt 1,2, Michael
More informationCHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement
CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement Evidence-Based Assessment of Diagnostic Tests for Ventilator- Associated Pneumonia* Executive Summary Ronald F. Grossman, MD, FCCP; and Alan Fein, MD,
More informationLaboratory diagnosis of congenital infections
Laboratory diagnosis of congenital infections Laboratory diagnosis of HSV Direct staining Tzanck test Immunostaining HSV isolation Serology PCR Tzanck test Cell scrape from base of the lesion smear on
More informationTerapia della candidiasi addomaniale
Verona 16 marzo 2018 Terapia della candidiasi addomaniale Pierluigi Viale Infectious Disease Unit Teaching Hospital S. Orsola Malpighi Bologna INTRA ABDOMINAL CANDIDIASIS open questions a single definition
More informationpoint-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital
point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital laboratory performed by a health care professional or non-medical
More informationCommunity Acquired & Nosocomial Pneumonias
Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP
More informationOne-year mortality in patients requiring prolonged mechanical ventilation: multicenter evaluation of the ProVent score
Leroy et al. Critical Care 2014, 18:R155 RESEARCH Open Access One-year mortality in patients requiring prolonged mechanical ventilation: multicenter evaluation of the ProVent score Guillaume Leroy 1, Patrick
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: The National Heart, Lung, and Blood Institute Acute Respiratory
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients
More informationClinical Practice Management Guideline for Ventilator-Associated Pneumonia: Diagnosis, Treatment & Prevention
Clinical for Ventilator-Associated Pneumonia: Diagnosis, Treatment & Prevention Background Ventilator-associated pneumonia (VAP), a pneumonia that develops 48hrs after initiation of mechanical ventilation,
More informationVAP in COPD patients. Ignacio Martin-Loeches. St James s University Hospital. Trinity Centre for Health Sciences. Dublin Ireland.
VAP in COPD patients Ignacio Martin-Loeches St James s University Hospital. Trinity Centre for Health Sciences. Dublin Ireland. Outline Pathophysiology Is enough information? COPD trends in ICU How do
More informationCytomegalovirus (CMV) Viral Load in Bronchoalveolar Lavage Fluid (BALF) and Plasma to Diagnose Lung Transplant Associated CMV Pneumonia
Cytomegalovirus (CMV) Viral Load in Bronchoalveolar Lavage Fluid (BALF) and Plasma to Diagnose Lung Transplant Associated CMV Pneumonia I.P. Lodding 1,2, H.H. Schultz 3, J.U. Jensen 1,5, C. Andersen 4,
More informationViral Threat on Respiratory Failure
Viral Threat on Respiratory Failure Younsuck Koh, MD, PhD, FCCM Department of Pulmonary and Critical Care Medicine Asan Medical Center University of Ulsan College of Medicine Seoul, Korea No Conflict of
More informationInfections with mimivirus in patients with chronic obstructive pulmonary disease
Respiratory Medicine (2012) 106, 1690e1694 Available online at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Infections with mimivirus in patients with chronic obstructive pulmonary
More informationThe rise of Tropheryma whipplei: a 12- year retrospective study of PCR diagnoses in our. reference center
JCM Accepts, published online ahead of print on 26 September 2012 J. Clin. Microbiol. doi:10.1128/jcm.01517-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 The rise of Tropheryma
More informationABSTRACT PURPOSE METHODS
ABSTRACT PURPOSE The purpose of this study was to characterize the CDI population at this institution according to known risk factors and to examine the effect of appropriate evidence-based treatment selection
More informationOutcomes of Moderate-to-Severe Pneumocystis Pneumonia Treated with Adjunctive Steroid in Non-HIV-Infected Patients
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2011, p. 4613 4618 Vol. 55, No. 10 0066-4804/11/$12.00 doi:10.1128/aac.00669-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Outcomes
More informationVentilator Associated Pneumonia. ICU Fellowship Training Radboudumc
Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results
More informationclinical investigations in critical care The Role of Open-Lung Biopsy in ARDS*
clinical investigations in critical care The Role of Open-Lung Biopsy in ARDS* Sanjay R. Patel, MD; Dimitri Karmpaliotis, MD; Najib T. Ayas, MD; Eugene J. Mark, MD; John Wain, MD, FCCP; B. Taylor Thompson,
More informationLack of Significant Co-Activation of BKV and CMV in Renal Transplant Patients: An Institutional Experience
Volume 1, Issue 1, pp: 1-6 Research Article Introduction Open Access Lack of Significant Co-Activation of BKV and CMV in Renal Transplant Patients: An Institutional Experience Minh-Thu Nguyen, BS 1, Phylicia
More informationHospital-acquired Pneumonia
Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired
More informationOutcomes From Severe ARDS Managed Without ECMO. Roy Brower, MD Johns Hopkins University Critical Care Canada Forum Toronto November 1, 2016
Outcomes From Severe ARDS Managed Without ECMO Roy Brower, MD Johns Hopkins University Critical Care Canada Forum Toronto November 1, 2016 Severe ARDS Berlin Definition 2012 P:F ratio 100 mm Hg Prevalence:
More informationWHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?
WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? Assoc. Prof. Dr. Serkan SENER Acibadem University Medical School Department of Emergency Medicine, Istanbul Acibadem Ankara Hospital,
More informationIs ARDS Important to Recognize?
Is ARDS Important to Recognize? Lorraine B. Ware MD Vanderbilt University Financial Disclosures: research funding from Boehringer Ingelheim, Global Blood Therapeutics Why diagnose ARDS? -initiate specific
More informationClinical Infectious Diseases Advance Access published April 11, What is the real role of respiratory viruses in severe community-acquired
Clinical Infectious Diseases Advance Access published April 11, 2014 1 What is the real role of respiratory viruses in severe community-acquired pneumonia? Olli Ruuskanen 1 and Asko Järvinen 2 1 Department
More informationVentilator Associated Pneumonia. ICU Fellowship Training Radboudumc
Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results
More informationLandmark articles on ventilation
Landmark articles on ventilation Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity ARDS AECC DEFINITION-1994 ALI Acute onset Bilateral chest infiltrates PCWP
More informationBicarbonates pour l acidose : BICAR-ICU
JAVA Créteil 1 décembre 2019 Bicarbonates pour l acidose : BICAR-ICU Samir JABER Department of Critical Care Medicine and Anesthesiology (DAR B) Saint Eloi University Hospital and Montpellier School of
More informationSoshi Hashimoto 1 and Nobuaki Shime 1,2*
Hashimoto and Shime Journal of Intensive Care 2013, 1:2 RESEARCH Open Access Evaluation of semi-quantitative scoring of Gram staining or semi-quantitative culture for the diagnosis of ventilator-associated
More informationDiagnosis of Ventilator-Associated Pneumonia: A Pilot, Exploratory Analysis of a New Score Based on Procalcitonin and Chest Echography
CHEST 2014; 146(6): 1578-1585 文献精读 Diagnosis of Ventilator-Associated Pneumonia: A Pilot, Exploratory Analysis of a New Score Based on Procalcitonin and Chest Echography Giovanni Zagli, MD, PhD ; Morena
More informationESCMID Online Lecture Library. by author
INFLUENZA IN CHILDREN Cristian Launes Infectious Diseases Unit. Department of Paediatrics. Hospital Sant Joan de Déu (Universitat de Barcelona) Innovation in Severe Acute Respiratory Infections (SARI),
More informationRelationship between Herpes Simplex Virus Type- 1 and periodontitis
Relationship between Herpes Simplex Virus Type- 1 and Hind Wael Al-Alousi, B.Sc. (1) Sana A. AL-Shaikhly, B.Sc. M. Sc., Ph. D. (2) ABSTRACT Background: HSV-1 is responsible for the most commonly occurring
More informationChapter 22. Pulmonary Infections
Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired
More informationSample Selection, Collection, Transport: Issues & Challenges
Sample Selection, Collection, Transport: Issues & Challenges Jim Dunn, PhD, D(ABMM) Director, Medical Microbiology and Virology Texas Children s Hospital LEARNING OBJECTIVES 1. Identify factors to consider
More informationJean-Yves Fagon,* Jean Chastre, Yves Domart, Jean-Louis Trnuillet, and Claude Gibert
538 Mortality Due to Ventilator-Associated Pneumonia or Colonization with Pseudomonas or Acinetobacter Species: Assessment by Quantitative Culture of Samples Obtained by a Protected Specimen Brush Jean-Yves
More informationSevere Dengue Infection in ICU. Shirish Prayag MD, FCCM Pune, India
Severe Dengue Infection in ICU Shirish Prayag MD, FCCM Pune, India Greetings from India Declaration Honararia from MSD, Astra Zenecea, Fresenius Kabi, Pfizer, Intas, Glenmark for conducting lectures. No
More informationChapter 8. General discussion and summary
Chapter8 Generaldiscussionandsummary 113 Generaldiscussionandsummary Generaldiscussionandsummary Thepresentthesisdescribesthesearchfornewdiagnosticmodalitiesandtechniquesin ventilatorassociated pneumonia
More informationLate diagnosis of influenza in adult patients during a seasonal outbreak
ORIGINAL ARTICLE Korean J Intern Med 2018;33:391-396 Late diagnosis of influenza in adult patients during a seasonal outbreak Seong-Ho Choi 1, Jin-Won Chung 1, Tark Kim 2, Ki-Ho Park 3, Mi Suk Lee 3, and
More informationAntimicrobial Stewardship in Community Acquired Pneumonia
Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis
More informationPREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP) PATIENTS OF INTENSIVE CARE UNIT (ICU) IN MAHARASHTRA REGION.
Original research article International Journal of Medical Science and Education pissn- 2348 4438 eissn-2349-3208 PREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP)
More informationGuess or get it right?
Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders
More informationYear in Review Intensive Care Training Program Radboud University Medical Centre Nijmegen
Year in Review 2013 Intensive Care Training Program Radboud University Medical Centre Nijmegen Contents ARDS Ventilator associated pneumonia Tracheostomy and endotracheal intubation Enteral feeding Fluid
More informationResearch & Reviews of. Pneumonia
Chapter Clinical Presentation and Diagnosis of VAP in Adult ICU Patients Priyam Batra * ; Purva Mathur Research & Reviews of Department of Laboratory Medicine, AIIMS, Trauma Centre, New Delhi, India. *
More informationLab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) MIC AMAL ALGHAMDI 1
Lab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) 2018 450 MIC AMAL ALGHAMDI 1 Learning Outcomes The pathogenesis of viral infection The viral disease pattern Specific
More informationMethods ROLE OF OPEN LUNG BIOPSY IN PATIENTS WITH DIFFUSE LUNG INFILTRATES AND ACUTE RESPIRATORY FAILURE
ROLE OF OPEN LUNG BIOPSY IN PATIENTS WITH DIFFUSE LUNG INFILTRATES AND ACUTE RESPIRATORY FAILURE Li-Hui Soh, Chih-Feng Chian, Wen-Lin Su, Horng-Chin Yan, Wann-Cherng Perng, and Chin-Pyng Wu Background
More informationComplications after HSCT. ICU Fellowship Training Radboudumc
Complications after HSCT ICU Fellowship Training Radboudumc Type of HSCT HSCT Improved outcome due to better HLA matching, conditioning regimens, post transplant supportive care Over one-third have pulmonary
More informationDo PPIs Reduce Bleeding in ICU? Revisiting Stress Ulcer Prophylaxis. Deborah Cook
Do PPIs Reduce Bleeding in ICU? Revisiting Stress Ulcer Prophylaxis Deborah Cook ICU-Acquired Upper GI Bleeding Case series of 300 ICU patients describing stressrelated erosive syndrome Frequent Fatal
More informationAssociation between Medical Costs and the ProVent Model in Patients Requiring Prolonged Mechanical Ventilation
ORIGINAL ARTICLE https://doi.org/10.4046/trd.2018.0065 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis, Respir Dis 2019;82:166-172 Association between Medical Costs and the ProVent Model in
More informationSoluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 as a Marker of Microbial Infection
Clinical Medicine & Research Volume 2, Number 3: 181-187 2004 Clinical Medicine & Research http://www.mfldclin.edu/clinmedres Review Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1
More informationBack to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures
More informationBACTERIOLOGY OF POSTOPERATIVE PNEUMONIA EOLE STUDY Dupont H ICM 2003, 29,
Pneumonies: classification Pneumonies communautaires Pneumonies associées aux soins Non nosocomiales Nosocomiales Malade ventilé précoces tardives Malade non ventilé The concept of Health Care Associated
More informationMicrobiology Laboratory Directors, Infection Preventionists, Primary Care Providers, Emergency Department Directors, Infectious Disease Physicians
MEMORANDUM DATE: October 1, 2009 TO: FROM: SUBJECT: Microbiology Laboratory Directors, Infection Preventionists, Primary Care Providers, Emergency Department Directors, Infectious Disease Physicians Michael
More informationEpidemiological and Microbiological Analysis of Ventilator-Associated Pneumonia Patients in a Public Teaching Hospital
482 BJID 2007; 11 (October) Epidemiological and Microbiological Analysis of Ventilator-Associated Pneumonia Patients in a Public Teaching Hospital João Manoel da Silva Júnior 1, Ederlon Rezende 1, Thaís
More informationInfections in immunocompromised host
Infections in immunocompromised host Immunodeficiencies Primary immunodeficiencies Neutrophil defect Humoral: B cell defect Humoral: Complement Cellular: T cells Combined severe immunodeficiency Secondary
More informationSupplementary Material. Mühlethaler et al.
Supplementary Material. Mühlethaler et al. Bronchoalveolar lavage (BAL) processing and polymerase chain reaction (PCR) methods The BAL procedure was performed following a standardized protocol by an experienced
More informationPortugal. From SACiUCI to InfAUCI. Sepsis epidemiology: an update. You re only given a little spark of madness. You mustn t lose it.
Sepsis epidemiology: an update Portugal João Gonçalves Pereira ICU director Vila Franca Xira Hospital From SACiUCI to InfAUCI You re only given a little spark of madness. You mustn t lose it. Robin Williams
More informationUPDATE IN HOSPITAL MEDICINE
UPDATE IN HOSPITAL MEDICINE FLORIDA CHAPTER ACP MEETING 2016 Himangi Kaushal, M.D., F.A.C.P. Program Director Memorial Healthcare System Internal Medicine Residency DISCLOSURES None OBJECTIVES Review some
More informationIdentification of Microbes Lecture: 12
Diagnostic Microbiology Identification of Microbes Lecture: 12 Electron Microscopy 106 virus particles per ml required for visualization, 50,000-60,000 magnification normally used. Viruses may be detected
More informationSEPSIS RESULTING FROM PNEUMONIA FILE
13 January, 2018 SEPSIS RESULTING FROM PNEUMONIA FILE Document Filetype: PDF 521.12 KB 0 SEPSIS RESULTING FROM PNEUMONIA FILE Aspiration pneumonia is a type of lung infection. CAP's symptoms are the result
More informationInfluenza-Associated Pediatric Deaths Case Report Form
STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Form approved OMB No. 0920-0007 Last Name: First Name: County: Address: City: State, Zip: Patient Demographics 1. State: 2. County: 3. State
More informationNIV in hypoxemic patients
NIV in hypoxemic patients Massimo Antonelli, MD Dept. of Intensive Care & Anesthesiology Università Cattolica del Sacro Cuore Rome - Italy Conflict of interest (research grants and consultations): Maquet
More informationTrial protocol - NIVAS Study
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Trial protocol - NIVAS Study METHODS Study oversight The Non-Invasive Ventilation after Abdominal Surgery
More informationRepeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia
ORIGINAL ARTICLE Repeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia Chiung-Zuei Chen, 1 Po-Sheng Fan, 2 Chien-Chung
More informationComparative detection of enterovirus RNA in cerebrospinal fluid: GeneXpert system vs. real-time RT-PCR assay
ORIGINAL ARTICLE VIROLOGY Comparative detection of enterovirus RNA in cerebrospinal fluid: GeneXpert system vs. real-time RT-PCR assay L. Ninove 1,2, A. Nougairede 1,2, C. Gazin 1, C. Zandotti 1, M. Drancourt
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationFluid Treatments in Sepsis: Meta-Analyses
Fluid Treatments in Sepsis: Recent Trials and Meta-Analyses Lauralyn McIntyre MD, FRCP(C), MSc Scientist, Ottawa Hospital Research Institute Assistant Professor, University of Ottawa Department of Epidemiology
More informationAntimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association
Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Els Vandecasteele, Jan De Waele, Dominique Vandijck, Stijn Blot, Dirk
More informationMaternal oral CMV recurrence following postnatal primary infection in infants
Maternal oral CMV recurrence following postnatal primary infection in infants I. Boucoiran, B. T. Mayer, E. Krantz, S. Boppana, A. Wald, L. Corey, C.Casper, J. T. Schiffer, S. Gantt No conflict of interest
More information11/19/2012. The spectrum of pulmonary diseases in HIV-infected persons is broad.
The spectrum of pulmonary diseases in HIV-infected persons is broad. HIV-associated Opportunistic infections Neoplasms Miscellaneous conditions Non HIV-associated Antiretroviral therapy (ART)-associated
More informationHerpes virus co-factors in HIV infection
Herpes virus co-factors in HIV infection Dr Jane Deayton Barts and the London Queen Mary School of Medicine Introduction Herpes viruses very common and often coexist with HIV Establish life-long latent
More information